Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2605)	9/25/2009 1:21:32 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

DRRX is among the few Biotechs showing some advances today. The stock has been helped by its presentation on Wednesday and today.<g> It is still up 10% after finding support at the $2.40 level. Volume is >10x its ADV. bigcharts.marketwatch.com DRRX has reported lower revenues in the last 2Qs and the loss for the current Yr. is expected around $0.38 unchanged from 2008 DRRX has NSLTD. Today's advance besides the 2 recent presentations, is probably related to short covering, since although down 6% in the last month, the short ratio was still about 10.8x its ADV.<g> The stock has a good amount of resistance at the $3 level. bigcharts.marketwatch.com With some good news and a close above $3 it could get to the $4 level.(The ACTAY is $4.13)<g> bigcharts.marketwatch.com Bernard

To: Jibacoa who wrote (2605)	6/23/2010 12:53:52 PM
From: Jibacoa	1 Recommendation Read Replies (1) \| Respond to of 3722

ZIOP is trading up for 2nd day on a roll, apparently with the help of a positive note from Emerging Stock Report.<g> The stock is still up 6.39% on volume almost 1/3 its ADV bigcharts.marketwatch.com ZIOP trimmed its loss last Yr., but it started the current Yr. with a larger loss on the 1stQ and the L for 2010 is estimated around $0.85 vs. $0.55 in 2009 The ACTAY is $8.67 But it seems that the stock has a good amount of resistance at the $44.20 and $5 levels.<g> bigcharts.marketwatch.com Bernard